Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention

NCT05241431 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT05241431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05241431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention
Lead sponsor
University of Aarhus
Phase
Phase 2/3
Overall status
Unknown status
Start date
February 12, 2022
Completion date
April 1, 2024
Enrollment
106 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, left ventricle hypertrophied